UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037560
Receipt number R000042328
Scientific Title Verification of usefulness of cardiac telerehabilitation for elderly patients with heart failure
Date of disclosure of the study information 2019/08/01
Last modified on 2023/08/28 14:21:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of usefulness of cardiac telerehabilitation for elderly patients with heart failure

Acronym

e-FIT HF trial

Scientific Title

Verification of usefulness of cardiac telerehabilitation for elderly patients with heart failure

Scientific Title:Acronym

e-FIT HF trial

Region

Japan


Condition

Condition

Heart failure

Classification by specialty

Cardiology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect on exercise capacity of combination therapy of conventional outpatient cardiac rehabilitation (CR) and cardiac telerehabilitation for elderly patients with heart failure.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Percentage of patients who improved peak VO2 by more than 6% after three months of CR

Key secondary outcomes

The rate of change of the following indicators during three months of CR
1. Peak VO2
2. Peak work rate
3. 6-minute walking distance
4. Brain natriuretic peptide
5. Body weight
6. Body composition
7. Nutritional index
8. Depression index
9. Serum lipid level
10. Blood sugar level, HbA1c
11. Renal function
12. Blood pressure
13. Heart failure self-care ability

The following indicators during three months of CR
14. Physical activity
15. Rate of smoking cessation
16. Participation rate in CR


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Combination therapy of conventional outpatient CR and cardiac telerehabilitation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients who are indicated for outpatient CR
2. Patients with heart failure
3. Patients with written consent
4. Over 60 years old

Key exclusion criteria

1. NYHA class 4
2. Patients with LVEF of 40% or less who developed myocardial infarction within 90 days
3. History of syncope or cardiopulmonary arrest(CPA) with unknown cause or no treatment
4. History of syncope, CPA or ICD/CRT-D appropriate or inappropriate therapy within the past one year(Patients with implantable devices are excluded after April 24, 2020)
5. Unstable angina or lower threshold angina
6. Severe stenotic valvular disease
7. The Following adverse events occur when the exercise intensity is less than the anaerobic threshold at the time of symptom-limited exercise test or CR before cardiac telerehabilitation introduction
7.1 Nonsustained/sustained ventricular tachycardia or ventricular fibrillation
7.2 R on T type ventricular premature contraction (VPC)
7.3 Frequent VPC (more than 30%)
7.4 Couplet VPC (two or more times a minute)
7.5 Second- or third-degree atrioventricular block
7.6 progressive blood pressure drop during exercise
7.7 Vagal reflexes after exercise below the exercise prescription intensity (Vagal reflexes after symptom-limited exercise test are not included in the exclusion criteria)
8. Schedule within three months for cardiovascular surgery, and implantation of pacemakers (including CRT) and ICDs
9. Patients with ventricular assist devices
10. End-stage patients
11. Patients who have difficulty operating the cardiac telerehabilitation system
12. Patients who can not establish a telecommunication system at home
13. Patients who have difficulty in securing time for participation in CR due to working or schooling
14. Patients who have already participated in or plan to participate in other clinical trials (except for registry studies)
15. Patients for whom the study investigator or the attending physician judged inappropriate to participate in this study

Target sample size

58


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Miura

Organization

National Cerebral and Cardiovascular Center

Division name

Cardiovascular medicine

Zip code

564-8565

Address

6-1 Kishibe Shinmachi, Suita, Osaka, Japan

TEL

06-6170-1070

Email

h_miura8217@yahoo.co.jp


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Miura

Organization

National Cerebral and Cardiovascular Center

Division name

Cardiovascular medicine

Zip code

564-8565

Address

6-1 Kishibe Shinmachi, Suita, Osaka, Japan

TEL

06-6170-1070

Homepage URL


Email

h_miura8217@yahoo.co.jp


Sponsor or person

Institute

National Cerebral and Cardiovascular Center

Institute

Department

Personal name



Funding Source

Organization

Ministry of education, culture, sports, science and technology (Japan Society for the Promotion of Science)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

Remohab Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cerebral and Cardiovascular Center

Address

6-1 Kishibe Shinmachi, Suita, Osaka, Japan

Tel

06-6170-1070

Email

h_miura8217@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立循環器病研究センター(大阪府)


Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 01 Day


Related information

URL releasing protocol

None

Publication of results

Unpublished


Result

URL related to results and publications

None

Number of participants that the trial has enrolled

5

Results

No analysis due to study discontinuation
(Study discontinued due to failure to reach sufficient number of patients)

Results date posted

2023 Year 08 Month 28 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

No analysis due to study discontinuation

Participant flow

No analysis due to study discontinuation

Adverse events

No analysis due to study discontinuation

Outcome measures

No analysis due to study discontinuation

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2019 Year 05 Month 15 Day

Date of IRB

2019 Year 06 Month 20 Day

Anticipated trial start date

2019 Year 08 Month 13 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 07 Month 31 Day

Last modified on

2023 Year 08 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042328


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name